Overview
Neuropsychopharmacology, published by Springer Nature (United States), published 1,374 papers in 2021–2025, and its papers received 195,936 citations in those years. Its h-index is 306 and its two-year mean citedness is 5.03. On the ITS Journal Score it ranks #890 of 62,158 ranked journals and #21 of 364 in Neuroscience.
Key figures
Citations count every citation the journal's papers received in these years, including citations to older papers. Two-year mean citedness is OpenAlex's measure of how often recent papers are cited; it is similar in idea to, but not the same as, an impact factor.
Papers and citations by year
| Year | Papers | Citations received | Open-access papers |
|---|---|---|---|
| 2020 | 345 | 40,264 | 337 |
| 2021 | 321 | 41,784 | 320 |
| 2022 | 271 | 38,658 | 271 |
| 2023 | 260 | 37,757 | 260 |
| 2024 | 262 | 38,957 | 262 |
| 2025 | 260 | 38,780 | 227 |
What it publishes
The leading research topics of its papers (OpenAlex topic classification). Select a topic to find other journals that publish on it.
Similar journals
Ranked journals that publish on the same topics.
| Journal | Field | Score | Papers 2021–2025 | Open access |
|---|---|---|---|---|
| Progress in Neuro-Psychopharmacology and Biological Psychiatry | Neuroscience | 80.4 | 1,154 | 41% |
| Addiction Biology | Neuroscience | 73.7 | 614 | 79% |
| The International Journal of Neuropsychopharmacology | Neuroscience | 66.7 | 1,618 | 100% |
| Molecular Psychiatry | Neuroscience | 90.2 | 2,457 | 79% |
| Neuroscience & Biobehavioral Reviews | Neuroscience | 89.7 | 2,201 | 65% |
| Journal of Psychopharmacology | Neuroscience | 79.9 | 684 | 62% |
| Addiction Neuroscience | Neuroscience | 60.8 | 227 | 100% |
| Pharmacology Biochemistry and Behavior | Neuroscience | 77.6 | 655 | 41% |
Compare with similar journals (side by side with the two closest journals above)
Identity and sources
- ISSN-L: 0893-133X
- Print ISSN: 0893-133X
- Electronic ISSN: 1740-634X
- Publisher: Springer Nature
- Listed in DOAJ: Not yet checked
- Crossref: ISSN found in Crossref
- OpenAlex: S175030738
- Journal website: www.nature.com
Figures come from OpenAlex (papers, citations, h-index, topics), Crossref (ISSN check) and DOAJ (open-access listing and fees). They change as records are corrected, so treat them as a dated snapshot. This page does not state whether the journal is indexed in Scopus, Web of Science or PubMed.
Questions
What is the ITS Journal Score of Neuropsychopharmacology?
It is 84.7 out of 100, which places it #890 among ranked journals. The score combines citation impact (45%), h-index (35%) and size (20%) from open OpenAlex data.
What is the impact factor of Neuropsychopharmacology?
This site does not publish Journal Impact Factors, which belong to Clarivate. As an open alternative, its two-year mean citedness in OpenAlex is 5.03.
Is Neuropsychopharmacology open access?
98% of its papers from 2021–2025 are recorded as open access.
Does Neuropsychopharmacology charge a publication fee?
No fee is recorded in the open data used here. Check the journal's own website for its current fees.